| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |